Navigation Links
Sickle cell disease corrected in human models using stem cell-based gene therapy

In a study to be published in the January 2006 issue of Nature Biotechnology, researchers led by a team of scientists at Memorial Sloan-Kettering Cancer Center have devised a novel strategy that uses stem cell-based gene therapy and RNA interference to genetically reverse sickle cell disease (SCD) in human cells. This research is the first to demonstrate a way to genetically correct this debilitating blood disease using RNA interference technology.

To prevent the production of the abnormal hemoglobin that causes sickle cell disease, a viral vector was introduced in cell cultures of patients who have the disease. The vector carried a therapeutic globin gene harboring an embedded small interfering RNA precursor designed to suppress abnormal hemoglobin formation. Tested in adult stem cells from SCD patients, researchers found that the newly formed red blood cells made normal hemoglobin and suppressed production of the sickle shaped hemoglobin typical of the disease.

"Sickle cell disease can only be cured by transplanting healthy blood-forming stem cells from another individual, but this option is not available to most patients due to the difficulty in finding a compatible donor," explained Michel Sadelain, MD, PhD, of the Immunology Program at MSKCC and the study's senior author. "By using gene transfer, there is always a donor match because the patient's own stem cells are used to treat the disease."

Sickle cell disease is a genetic condition that causes an abnormal type of hemoglobin to be made in red blood cells. The aggregation of hemoglobin S inside red cells interferes with the body's blood cells' ability to flow through small blood vessels, depriving tissues of adequate oxygen supply. This can cause pain, anemia, infections, organ damage, and stroke. Approximately 80,000 people in the United States have this inherited condition, which is primarily found in people of African, Mediterranean, Indian, or Middle Eastern origin. There is no kn
'"/>

Source:Memorial Sloan-Kettering Cancer Center


Page: 1 2

Related biology news :

1. Discovery Promises Simpler Therapy for Sickle Cell Disease
2. Sickle cell and protection against malaria
3. Neuronal traffic jam marks early Alzheimers disease
4. Scientists detect probable genetic cause of some Parkinsons disease cases
5. Ecological destruction fuels emerging diseases
6. Newly discovered virus linked to childhood lung disorders and Kawasaki disease
7. U of M researcher examines newly emerging deadly disease
8. Marburg virus disease in Angola - update
9. Molecular machine may lead to new drugs to combat human diseases
10. Female sex hormones play a vital role in defense against sexually transmitted diseases
11. A bacterial genome reveals new targets to combat infectious disease

Post Your Comments:
(Date:11/24/2009)...level action of a remarkable class of ring-shaped ...ith the Lawrence Berkeley National Laboratory (Ber...llography beamline at the Advanced Light Source (A...ne expression and replication, and are vital to th...ectious agents, such as the human papillomavirus, ...
(Date:11/24/2009)...itutes fish food is a matter of debate. A high-pro... almost 50 percent of their carbon from trees and ... terrestrial and aquatic ecosystems. , But new r...is is not likely to be true. Algae provide a much ...ding to research published this week in the Proce...
(Date:11/23/2009)... D.C. The community-associated strain of the dead...stant to most common antibioticsposes a far greate...g its way into hospitals, according to a study in ...s . , The new threat is easily picked up in fit... has increased the overall burden of MRSA within h...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3New study finds MRSA on the rise in hospital outpatients 2USAID Brings White House Service Initiative to Baltimore 49829 1USAID Brings White House Service Initiative to Baltimore 49829 2USAID Brings White House Service Initiative to Baltimore 49829 3Fenwal to Host Webinar on the Safety of 2 Unit Red Cell Collections From Young Donors 49825 1Fenwal to Host Webinar on the Safety of 2 Unit Red Cell Collections From Young Donors 49825 2Fenwal to Host Webinar on the Safety of 2 Unit Red Cell Collections From Young Donors 49825 3Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies 4637 1Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies 4637 2Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies 4637 3
...earchers from the University of North Carolina at ...ism that may account for the development of cystic... with in the US every year. The findings, publish...putational Biology, add new knowledge to understan...point the way to new corrective treatments. , Cys...
... National Heart, Lung, and Blood Institute (NHLBI)...d the first clinical guidelines in the United Stat...and Disease (VWD), the most common inherited bleed...ns on screening, diagnosis, disease management, an...icle on the guidelines is published online Feb. 29...
... YORK (Feb. 29, 2008) -- Teens who can recognize a...ds are less likely to succumb to alcohol advertisi... three-year study of inner-city middle school stud...appears online in the journal Addictive Behaviors ... the connection between advertising and adolescent...
Other Biology News:Computer simulations point to key molecular basis of cystic fibrosis 2NHLBI issues first US von Willebrand Disease clinical practice guidelines 2NHLBI issues first US von Willebrand Disease clinical practice guidelines 3NHLBI issues first US von Willebrand Disease clinical practice guidelines 4Learning how to say 'no' to alcohol advertising and peer pressure works for inner-city adolescents 2
(Date:11/25/2009)... , NEW YORK, Nov. 25 Repor...eport is available in its catalogue: ,, Brazil... ,, http://www.reportlinker.com/p0165503/Brazi....html ,, Brazil Bioethanol Market Analysis and...t provides detailed analysis and forecasts of the ...
(Date:11/24/2009)... Ambassador to also Visit Detroi...2009 -- , , ,Who: David Appia, French Ambassador f...of the Invest in France Agency, , , , ,What: Amba...scuss recent pro-business initiatives adopted by F... academic landscape for innovation and development...
(Date:11/24/2009)... , REYKJAVIK, Iceland, November.... (Nasdaq: DCGN ) today announced that it has rece...ing in the company,s common stock will be,suspende...e filed with the,Securities and Exchange Commissio...sting on Nasdaq, unless the company files an appea...
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia/ --...& Trademark Office (PTO) has allowed the paten...or NOD technology. , NOD technology is a ...or,proteins into bio-adhesive nano-particles to en... as injections. NOD technology is a platform techn...
Breaking Biology Technology:Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3
...he rising demand for low-cost, small-size, high-sp...mmunications, the development of highly-integrated... have received much attention in recent years. The...eet the rising demand, especially for unlicensed 5...ntenna designs have been too large, expensive and ...
..., Oct. 21 Cadence Pharmaceuticals,Inc. (Nasdaq: ...licensing,developing and commercializing proprieta...ospital setting, announced today that the company,...t the company,s corporate,overview on Tuesday, Oct...ern Time) during the BIOCOM Investor Conference at...
... Oct. 21 Golub Capital today announced that it,ha...DNA Diagnostics Center,Inc. (DDC) by MTS Health In...y Golub Capital One-Loan Debt facilities. Terms of...in Fairfield, Ohio, is one of the largest and most...the market leader in human DNA,identification test...
Other Biology Technology:NTU and SIMTech announce the first antenna-in-package solution for single-chip 60 GHz radio 2Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the BIOCOM Investor Conference 2Golub Capital Provides Debt Financing to Support the Acquisition of DNA Diagnostics Center, Inc. by MTS Health Investors, LLC 2
Calcium Phosphate Transfection Kit from Invitrogen
Custom siRNA, HPLC purified from Ambion
Silencer Pre-designed siRNA, standard purity, annealed from Ambion
Minimal Essential Medium Alpha Medium (Custom) from Invitrogen
Biology Products: